Immune checkpoint blockade therapy in head and neck cancer: a review

• Hauptverfasser: Shajedul Islam (Verfasst von), Md Shahed Rafi Pavel (Verfasst von), Syed Taufiqul Islam (Verfasst von), Nazmus Shalehin (Verfasst von), Shahed Jahan Babu (Verfasst von)
• Format: Buch
• Veröffentlicht: Update Dental College, 2018-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the...